Oncolytics Biotech (ONCY) - 2023 Q2 - Quarterly Report

Condensed Interim Consolidated Financial Statements (unaudited) Oncolytics Biotech Inc. For the three months ended March 31, 2023 ® ONCOLYTICS BIOTECH INC. CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (unaudited) (in thousands of Canadian dollars, except share amounts) | | | March 31, | | December 31, | | --- | --- | --- | --- | --- | | As at | | 2023 | | 2022 | | Assets | | | | | | Current assets | | | | | | Cash and cash equivalents (note 4) | $| 15,872 |$ | 11,666 | | Marketable secu ...